(Q40596633)

English

Phase I/II trial of docetaxel and vinorelbine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy

scientific article published on October 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 September 2017

Phase I/II trial of docetaxel and vinorelbine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy (English)

1 reference

Europe PubMed Central

21 September 2017

phase I clinical trial

0 references

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

author name string

K M Leu

1

1 reference

Europe PubMed Central

21 September 2017

K M Kim

2

1 reference

Europe PubMed Central

21 September 2017

M Larson

3

1 reference

Europe PubMed Central

21 September 2017

M Larson

4

1 reference

Europe PubMed Central

21 September 2017

J H Schiller

5

1 reference

Europe PubMed Central

21 September 2017

publication date

1 October 2001

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

34

1 reference

Europe PubMed Central

21 September 2017

1

1 reference

Europe PubMed Central

21 September 2017

105-113

1 reference

Europe PubMed Central

21 September 2017

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900209-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900209-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900209-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial of Taxotere: five-day schedule

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900209-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900209-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel (Taxotere) is active in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group (ECTG)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900209-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900209-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900209-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900209-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900209-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900209-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900209-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Vinorelbine (Navelbine): a third-generation vinca alkaloid

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900209-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of vinorelbine compared with fluorouracil plus leucovorin in patients with stage IV non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900209-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900209-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer. Japan Vinorelbine Lung Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900209-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of docetaxel and vinorelbine in patients with advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900209-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900209-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0169-5002(01)00209-4

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40596633&oldid=1903505406"